Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab.
Saved in:
| Title: | Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab. |
|---|---|
| Authors: | Gerischer, Lea1,2 (AUTHOR), Stascheit, Frauke1,2 (AUTHOR), Mönch, Maximilian3 (AUTHOR), Doksani, Paolo1,2 (AUTHOR), Dusemund, Carla1,2 (AUTHOR), Herdick, Meret1,2 (AUTHOR), Mergenthaler, Philipp1,4,5 (AUTHOR), Stein, Maike1,2 (AUTHOR), Suboh, Amani1,2 (AUTHOR), Schröder‐Braunstein, Jutta6 (AUTHOR), Wabnitz, Guido6 (AUTHOR), Lünemann, Jan D.7 (AUTHOR), Lehnerer, Sophie1,2,8 (AUTHOR), Hoffmann, Sarah1,2 (AUTHOR), Meisel, Andreas1,2,4 (AUTHOR) andreas.meisel@charite.de |
| Source: | Annals of Clinical & Translational Neurology. Apr2026, Vol. 13 Issue 4, p688-699. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
